IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation
UMass Chan Affiliations
Department of Medicine, Division of Pulmonary, Allergy and Critical Care MedicineDocument Type
Journal ArticlePublication Date
2018-08-09Keywords
AutoimmunityChemokines
Immunology
Lupus
Neutrophils
Hemic and Immune Systems
Immune System Diseases
Immunopathology
Pathological Conditions, Signs and Symptoms
Pulmonology
Respiratory System
Respiratory Tract Diseases
Skin and Connective Tissue Diseases
Metadata
Show full item recordAbstract
Severe lung inflammation and alveolar hemorrhage can be life-threatening in systemic lupus erythematosus (SLE) patients if not treated early and aggressively. Neutrophil influx is the driver key of this pathology, but little is known regarding the molecular events regulating this recruitment. Here, we uncover a role for IL-16/mir-125a in this pathology and show not only that IL-16 is a target for miR-125a but that reduced miR-125a expression in SLE patients associates with lung involvement. Furthermore, in the pristane model of acute "SLE-like" lung inflammation and alveolar hemorrhage, we observed reduced pulmonary miR-125a and enhanced IL-16 expression. Neutrophil infiltration was markedly reduced in the peritoneal lavage of pristane-treated IL-16-deficient mice and elevated following i.n. delivery of IL-16. Moreover, a miR-125a mimic reduced pristane-induced IL-16 expression and neutrophil recruitment and rescued lung pathology. Mechanistically, IL-16 acts directly on the pulmonary epithelium and markedly enhances neutrophil chemoattractant expression both in vitro and in vivo, while the miR-125a mimic can prevent this. Our results reveal a role for miR-125a/IL-16 in regulating lung inflammation and suggest this axis may be a therapeutic target for management of acute lung injury in SLE.Source
JCI Insight. 2018 Aug 9;3(15). pii: 120798. doi: 10.1172/jci.insight.120798. Link to article on publisher's site
DOI
10.1172/jci.insight.120798Permanent Link to this Item
http://hdl.handle.net/20.500.14038/40752PubMed ID
30089723Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
Rights
Copyright © 2018, American Society for Clinical Investigation. Publisher pdf posted as allowed by the publisher's open access policy at https://insight.jci.org/kiosks/terms.ae974a485f413a2113503eed53cd6c53
10.1172/jci.insight.120798